Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.68
+0.64 (0.77%)
At close: Jul 28, 2026, 4:00 PM EDT
84.80
+1.12 (1.34%)
After-hours: Jul 28, 2026, 7:58 PM EDT

Edwards Lifesciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
1,7411,6491,5701,5531,5321,4131,3861,3541,3691,3301,2661,2431,2961,4601,3481,3191,3741,3411,3301,310
Revenue Growth (YoY)
13.63%16.70%13.26%14.67%11.89%6.23%9.43%8.93%5.70%-8.89%-6.07%-5.73%-5.71%8.83%1.40%0.67%-0.15%10.24%11.58%14.84%
Cost of Revenue
392.4362.6343345.2344.4301.6292.2262.9275.5286.9251250.6256.9329.5257.9253.8269.4299.3309.5311.7
Gross Profit
1,3491,2861,2271,2081,1881,1111,0941,0921,0941,0431,015992.81,0391,1301,0901,0651,1051,0421,020998.5
Selling, General & Admin
561.2522.2602.9514.6502465.7491.9421.4447.5428.4416.6381.9410.4436.3411377.3409370.3424364.4
Research & Development
278.9263.3267.7280.7276.2254.6271.1253.4271.8256.7242.1242.8243.7261.2232.2233.6250.8228.6232.8238
Other Operating Expenses
-4.722.9204.9105.5-1.6-41866.18.18.99.92.212144.2-0.651.9-14.84.2-115.8
Total Operating Expenses
835.4808.41,076900.8776.6716.3781740.9727.4694668.6626.9775.1741.7642.6662.8645603.1645.8608.2
Operating Income
513.2477.6151.1307.1411.2394.8312.6350.6366.5349346.8365.9263.5388.4447.8402.4459.5438.8374.4390.3
Total Non-Operating Income (Expense)
6.6-18.6-96.641.3-1139.133.352.217.522.23.621.711.610.27.94.95.2-2.7-0.6
Pretax Income
519.845990.4348.4400.2433.9390.1402.8384371.2367.2387.6275.1398.6459.3407.3464.7436.1376.3390.9
Provision for Income Taxes
278.478.326.256.164.370.345.140.72046.334.152.720.958.160.963.858.362.54150.8
Net Income
241.4380.764.2292.3335.9363.6345362.1364324.9333.1334.9254.2340.5398.4343.5406.4373.6335.3340.1
Minority Interest in Earnings
-0.5-0-0.8-1.7-1.6-1.3-1.4-1.3-0.9-0.2-1.2-1.6-------
Earnings From Discontinued Operations
--27-2-4.4-7.239.32,707126.136.648.851.3-------
Net Income to Common
241.9380.791.2291.1333.2358385.63,071366.3351.9369.9384.9307.1340.5398.4343.5406.4373.6335.3340.1
Net Income Growth (YoY)
-27.40%6.34%-76.35%-90.52%-9.04%1.73%4.24%697.82%19.28%3.35%-7.15%12.05%-24.43%-8.86%18.82%1.00%-16.98%10.47%8.34%4.58%
Shares Outstanding (Basic)
576579580585587587590597602602605607607608613620621622624624
Shares Outstanding (Diluted)
578581582586588588591598604604607610610611616625627629632632
Shares Change (YoY)
-1.75%-1.21%-1.47%-2.07%-2.71%-2.70%-2.70%-1.87%-0.98%-1.11%-1.51%-2.40%-2.62%-2.94%-2.50%-1.14%-0.51%-0.30%-0.11%
EPS (Basic)
0.420.660.160.500.570.610.655.140.610.580.610.630.510.560.650.550.650.600.540.55
EPS (Diluted)
0.420.660.160.500.560.610.655.130.610.580.610.630.500.560.650.550.650.590.530.54
EPS Growth (YoY)
-25.00%8.20%-75.39%-90.25%-8.20%5.17%6.56%714.29%22.00%3.57%-6.15%14.54%-23.08%-5.08%22.64%1.85%-16.67%9.26%8.16%3.85%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
0-21.1353.5516.2240.9224.4-177.3299.9286.1-118.848.3356.2-14.3252.6213.9250289.1220.6283.8471.2
Free Cash Flow Growth (YoY)
---72.12%-15.80%---15.81%---77.42%42.48%-14.51%-24.63%-46.94%-36.71%13.42%-0.98%317.73%
Free Cash Flow Per Share
--0.040.610.880.410.38-0.300.500.47-0.200.080.58-0.020.410.350.400.460.350.450.75
Gross Margin
77.46%78.01%78.15%77.77%77.52%78.65%78.91%80.59%79.88%78.43%80.18%79.85%80.17%77.43%80.87%80.76%80.39%77.68%76.72%76.21%
Operating Margin
29.48%28.97%9.63%19.77%26.84%27.95%22.56%25.89%26.76%26.24%27.38%29.43%20.34%26.61%33.21%30.51%33.44%32.72%28.16%29.79%
Profit Margin
13.87%23.09%4.09%18.82%21.92%25.74%24.90%26.74%26.58%24.43%26.30%26.93%19.62%23.33%29.55%26.04%29.58%27.86%25.22%25.96%
FCF Margin
0.00%-1.28%22.52%33.24%15.72%15.88%-12.79%22.14%20.89%-8.93%3.81%28.65%-1.10%17.31%15.86%18.95%21.04%16.45%21.34%35.96%
EBITDA
513.2518.5193.8346.3449.3431.4355.2385.1406.1387.5383.5402.8299.6423.6483.2437.8493.6473.5407.4423.9
EBITDA Margin
29.48%31.45%12.35%22.30%29.32%30.54%25.63%28.43%29.66%29.14%30.28%32.40%23.13%29.02%35.84%33.19%35.93%35.30%30.64%32.35%
EBIT
513.2477.6151.1307.1411.2394.8312.6350.6366.5349346.8365.9263.5388.4447.8402.4459.5438.8374.4390.3
EBIT Margin
29.48%28.97%9.63%19.77%26.84%27.95%22.56%25.89%26.76%26.24%27.38%29.43%20.34%26.61%33.21%30.51%33.44%32.72%28.16%29.79%
Effective Tax Rate
53.56%17.06%28.98%16.10%16.07%16.20%11.56%10.10%5.21%12.47%9.29%13.60%7.60%14.58%13.26%15.66%12.55%14.33%10.90%13.00%
SEC Filings: 10-K · 10-Q